These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36549962)

  • 21. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.
    Russell JA; Fjell C; Hsu JL; Lee T; Boyd J; Thair S; Singer J; Patterson AJ; Walley KR
    Am J Respir Crit Care Med; 2013 Aug; 188(3):356-64. PubMed ID: 23796235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study.
    Kulesza S; Gignac L; Colvin CA; Boll S; Giuliano C; Haan B; Allen B; Perez MM; Allen M; Edwin SB
    Pharmacotherapy; 2023 Aug; 43(8):787-794. PubMed ID: 37148191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.
    Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Laderchi A; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
    Crit Care; 2008; 12(6):R143. PubMed ID: 19017409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin pressor hypersensitivity in vasodilatory septic shock.
    Landry DW; Levin HR; Gallant EM; Seo S; D'Alessandro D; Oz MC; Oliver JA
    Crit Care Med; 1997 Aug; 25(8):1279-82. PubMed ID: 9267938
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
    Stolk RF; van der Poll T; Angus DC; van der Hoeven JG; Pickkers P; Kox M
    Am J Respir Crit Care Med; 2016 Sep; 194(5):550-8. PubMed ID: 27398737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
    Jakowenko ND; Murata J; Kopp BJ; Erstad BL
    J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
    [No Abstract]   [Full Text] [Related]  

  • 28. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
    Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
    Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM; Chittock DR; Russell JA; Walley KR
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis.
    Barrett LK; Orie NN; Taylor V; Stidwill RP; Clapp LH; Singer M
    Crit Care Med; 2007 Oct; 35(10):2337-43. PubMed ID: 17944022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock.
    Brask AL; Shemanski SM; Barnes TE; Holmes AK
    Ann Pharmacother; 2023 May; 57(5):521-526. PubMed ID: 36039490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin vs noradrenaline: Have we found the perfect recipe to improve outcome in septic shock?
    Chidambaram S; Goh EL; Rey VG; Khan MA
    J Crit Care; 2019 Feb; 49():99-104. PubMed ID: 30415181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of vasopressin on acute kidney injury in septic shock.
    Gordon AC; Russell JA; Walley KR; Singer J; Ayers D; Storms MM; Holmes CL; Hébert PC; Cooper DJ; Mehta S; Granton JT; Cook DJ; Presneill JJ
    Intensive Care Med; 2010 Jan; 36(1):83-91. PubMed ID: 19841897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of vasopressin in the treatment of refractory septic shock.
    Kny KT; Ferreira MAP; Pizzol TDSD
    Rev Bras Ter Intensiva; 2018; 30(4):423-428. PubMed ID: 30570030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.
    Sacha GL; Bauer SR
    Chest; 2023 Nov; 164(5):1216-1227. PubMed ID: 37479058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
    Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
    Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
    Hajjar LA; Zambolim C; Belletti A; de Almeida JP; Gordon AC; Oliveira G; Park CHL; Fukushima JT; Rizk SI; Szeles TF; Dos Santos Neto NC; Filho RK; Galas FRBG; Landoni G
    Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA; Lee T; Singer J; De Backer D; Annane D
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.